Victor W. van Beusechem
Technik-/Wissenschafts-/F&E-Leiter bei ORCA Therapeutics BV
Aktive Positionen von Victor W. van Beusechem
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ORCA Therapeutics BV
 ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Victor W. van Beusechem
Ehemalige bekannte Positionen von Victor W. van Beusechem
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Janssen Vaccines & Prevention BV
 Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 | 01.01.1998 |
| Introgene BV | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 | 01.01.1998 |
Ausbildung von Victor W. van Beusechem
| University of Leiden | Doctorate Degree |
| Vrije Universiteit Amsterdam | Undergraduate Degree |
Statistik
International
| Niederlande | 5 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ORCA Therapeutics BV
ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
| Introgene BV | Health Technology |
- Börse
- Insiders
- Victor W. van Beusechem
- Erfahrung
